We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Alliance to Develop New Modules for Live Cell Imaging

By Biotechdaily staff writers
Posted on 09 Jun 2006
A collaboration to develop innovative new fluorescence-detection modules for integration with the Cell-IQ live-cell culturing and analysis system of Chip-Man Technologies Ltd. (Tampere, Finland) has been announced by the company and by ArcDia Ltd. (Turku, Finland).

The new modules will be a first in live-cell imaging, enabling simultaneous measurement and analysis of cell events using both phase contrast and living dyes within the same culture under incubation.

Juha Korpinen, CEO, Chip-Man Technologies, said, "This development will greatly enhance the capabilities of the Cell-IQ to enable even more detailed information to be extracted from living cells. Professors Erkki Soini, Juhani Soini, and colleagues are widely respected in the field of fluorescence detection. We are very fortunate to have such key expertise available within our local academic institutions.”

Cell-IQ represents a major breakthrough in cell analysis by enabling real time monitoring of all morphologic and physiologic changes in cell lines, primary cells, co-cultures and monolayer tissue models. The Cell-IQ software "learns” to recognize and record cellular change and to output these results as real-time moving images and simple multi-parameter graphics.

The addition of a fluorescence detection module will enable the Cell IQ to identify specific siRNA and cDNA transcripts. This will allow them to be closely monitored and the resulting morphologic changes recorded within the population. Thus the measurement of the true rate of cellular stimulation to specific drugs will be possible. In addition researchers can select out those fluorophores that minimally affect cells or have a synergistic or antagonistic effect on target drugs, enabling better optimization and control of cell based experimentation.



Related Links:
Chip-Man Technologies

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Automated Immunoassay Analyzer
SuperFlex™
Manual Pipetting Aid
Pipette Controllers macro

Latest BioResearch News

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
09 Jun 2006  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
09 Jun 2006  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
09 Jun 2006  |   BioResearch